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Abstract: Coordinated by ataxia-telangiectasia-mutated (ATM) and ATM and Rad3-related (ATR),
two highly conserved kinases, DNA damage repair ensures genome integrity and survival in all
organisms. The Arabidopsis thaliana (A. thaliana) orthologues are well characterized and exhibit typical
mammalian characteristics. We mutated the Physcomitrella patens (P. patens) PpATM and PpATR genes
by deleting functionally important domains using gene targeting. Both mutants showed growth
abnormalities, indicating that these genes, particularly PpATR, are important for normal vegetative
development. ATR was also required for repair of both direct and replication-coupled double-strand
breaks (DSBs) and dominated the transcriptional response to direct DSBs, whereas ATM was far
less important, as shown by assays assessing resistance to DSB induction and SuperSAGE-based
transcriptomics focused on DNA damage repair genes. These characteristics differed significantly
from the A. thaliana genes but resembled those in yeast (Saccharomyces cerevisiae). PpATR was not
important for gene targeting, pointing to differences in the regulation of gene targeting and direct DSB
repair. Our analysis suggests that ATM and ATR functions can be substantially diverged between
plants. The differences in ATM and ATR reflect the differences in DSB repair pathway choices between
A. thaliana and P. patens, suggesting that they represent adaptations to different demands for the
maintenance of genome stability.
Keywords: Physcomitrella patens; DNA damage repair; double-strand break repair; phosphoinositide
3-kinase-related kinases; gene targeting; evolution; transcriptional control; development;
DNA recombination
1. Introduction
DNA damage caused by intrinsic and extrinsic factors constantly challenges genome stability [1].
Repair of DNA damage employs a complex network of interacting pathways, the DNA damage
response (DDR), comprising DNA damage sensing, signal integration, and signal transduction
processes that activate diverse DNA damage repair pathways and their connections to DNA replication
and cell-cycle control [2–5]. DNA double-strand breaks (DSBs) represent a lethal form of DNA
damage, as failure to repair such damage causes loss of genetic information and affects cellular
viability. DSB repair occurs by two principal pathways, non-homologous end-joining (NHEJ) and
homologous recombination (HR) [6,7], processes that differ in their requirement for a homologous
template, their precision and speed of repair, and their dependence on the state of the cell-cycle [5,8,9].
Central components in regulating cell-cycle arrest and DSB repair in mammals are the phosphoinositide
3-kinase-related kinase (PIKK) proteins ataxia-telangiectasia-mutated (ATM), ATM and Rad3-related
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(ATR), and the DNA-dependent protein kinase catalytic subunit (PRKDC) [10], two of which, ATM
and ATR, are evolutionarily conserved across all eukaryotes.
Ionizing radiation (IR) and radiomimetics such as bleomycin cause DSBs directly (direct DSBs)
while the DNA damage caused by a number of other agents such as mitomycin C is converted to
DSBs by replication (replication-coupled DSBs). In humans, atm mutants are markedly more sensitive
to agents causing direct DSBs than atr mutants, and atr, but not atm mutants, are highly sensitive
to agents introducing replication-coupled DSBs [8,9]. These resistance patterns suggest that ATM
and ATR are specialized to different types of DSBs and cooperate to build the central hub in the
human DDR [11,12]. Arabidopsis thaliana atm mutants are also highly sensitive to IR and methyl
methanesulfonate (MMS), but not UV-B [13] and the radiomimetic bleomycin [14], indicating the
importance of ATM in the repair of direct DSBs. Atatr mutants are less sensitive to IR [15] but are highly
sensitive to agents inducing replication-coupled DSBs such as replication blocking agents (aphidicolin,
UV-B, hydroxyurea) [15,16] and the inter-strand crosslinking agent mitomycin C [14]. These resistance
patterns suggest a comparable specialization of ATM and ATR functions in plants [17]. In addition,
ATM plays a leading role in the control of the transcriptional response to direct DSBs in A. thaliana,
whereas ATR is of minor importance [15,18].
Physcomitrella patens (P. patens) is the model moss representing the bryophytes in the land plant
lineage, the earliest diverging clade among the plants colonizing the land [19–21]. In addition, the high
efficiencies of gene targeting in P. patens [22], a process based on homology-mediated integration of
transforming DNA, are unique in the land plant lineage and contribute to the importance of this
organism as a model. Previous analyses of core recombination genes in HR (RAD51, RAD51 paralogue
B) demonstrated that HR is the preferred repair pathway for direct DSBs in P. patens, although NHEJ
contributes [23], whereas A. thaliana mainly relies on NHEJ [24–26]. In addtion, analyses of additional
recombination genes (MRE11–RAD50–NBS1 (MRN)) complex, MSH2, and RECQ) [27–29] showed the
importance of this process for DNA damage repair in P. patens. Analysis of the genes directly involved
in HR (RAD51, RAD51 paralogue B) showed that these are also essential for gene targeting [25,26,30]
and suggested that this process is solely based on RAD51-mediated recombination in P. patens, although
this dependence is restricted on gene targeting in the absence of DSB induction [31] Together with the
analyses of other genes [27–29], these data suggest a tight connection between DSB repair and gene
targeting in P. patens.
To analyze genes not directly involved in recombination, we mutated the P. patens ATM and
ATR genes by gene targeting. Characterization of the corresponding mutants and a double mutant
obtained by crossing showed that both mutations caused developmental aberrations in P. patens.
The atm mutant in P. patens was also only barely sensitive to bleomycin, and the transcriptional
control of major DNA damage repair genes was only marginally dependent on ATM. Rather, both the
transcriptional response induced by bleomycin and resistance to such damage was largely dependent
on ATR. By contrast, neither ATR nor ATM alone was important for gene targeting, but both together
they were. Our data highlight the importance of regulatory components in these processes and reveal
fundamental differences in the regulation of DSB repair and gene targeting as well as in ATM and ATR
functions between A. thaliana and P. patens.
2. Materials and Methods
2.1. Identification and Characterisation of PpATM and PpATR Genes
Genes were originally identified by homology searches using TBLASTN with the entire A.
thaliana protein sequences as query in the initial v1.1 gene model DNA sequences of the P.
patens genome [32]. Using total protonemal RNA as starting material and gene specific primers,
the corresponding complementary DNA (cDNAs) were amplified by PCR, cloned, and Sanger
sequenced. Finally, the extreme 5′ and 3′ ends of the transcripts were determined by 5′ and 3′ rapid
amplification of cDNA ends (RACE) (5′/3′ RACE Kit, Roche) using the same RNA as starting material
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and gene-specific primers located at terminal exons: ATM_Ex3_1_rev (CCA GAA CGT CCA TTA GTA
TGC AAT CG), ATR_Ex1_2_rev (CCT AAG ATT GGT AAC ACT GCA TGG C), ATM_Ex73_1_fwd
(CTG CTG ACA TGG ACA ACT CGG AG), and ATR_EX22_1_fwd (TCG AAA TCC TAG CCT CGC
TGC). Gaps were filled by long template PCR using gene-specific primers, the entire cDNA amplified
using primers at the extreme ends of the untranslated regions (UTRs), and PCR products cloned in
pGEM-t-easy (Invitrogen). The inserts were Sanger sequenced and final sequences were corrected for
PCR and sequencing errors using the genomic sequence as a template.
The protein sequences deduced from these sequences were compared to the entire collection of
non-redundant protein sequences in the European Nucleotide Archive (ENA)/GenBank collection using
BLASTP with default search parameter settings (https://blast.ncbi.nlm.nih.gov/Blast.cgi). These searches
exclusively retrieved ATM and ATR sequences at the top significance levels with ATM and ATR as
query from a large variety of different organisms. All other members of the PIKK family such as
PRKDC or mTOR followed with far less significant identity scores, thus confirming the identity of
these proteins as ATM and ATR. As an additional confirmation of their identity, the same genes are
annotated as PpATM ( Pp3c2_23700V3.1) and PpATR (Pp3c6_3460V3.1) in the version v3.3 models [33]
available in Phytozome (Physcomitrella patens v3.3, DOE-JGI, http://phytozome.jgi.doe.gov/) [34], which
are identical to them except for the 5′ and 3′ untranslated regions. In addition, ATM and ATR protein
sequences from representative organisms and sequenced plant genomes were retrieved from the
National Center for Biotechnology Information (NCBI) and Phytozome databases and the phylogeny of
these proteins across representative organisms were established (Figure 1B) using AlignX (VectorNTI
suite, Thermo Fisher Scientific) with the default settings of the program.
2.2. Production of Ppatm and Ppatr Mutants
Gene replacement vectors were designed to produce a deletion of 1809 bp in the PpATM gene,
which removes the last 6 exons (Physcomitrella patens v3.3, Chr02:15863420..15865228) from the genome
to replace it with a sulfonamide resistance gene [24]. The deletion in the PpATR gene covers 1680 bp
encoding the last 3 exons (Physcomitrella patens v3.3, Chr06:1980747.. 1982426) that are replaced by
the NPTII gene [24]. The corresponding gene replacement vectors were obtained as follows. The 5′
and 3′ regions of homology were obtained by long template PCR (Roche Expand long template PCR
kit) using P. patens wild type genomic DNA. For PpATM, primer pairs were for 5′ ATMup 1 (TTT
CCC GGG TCG ACG GAA CAG)/ATMup 2 (CAC CCA TGG ATG AGG AAC ATC AAG TAC) and 3′
ATMdown 1 (GGG GAG CTC ATA GAG GTG AGG CTA AAA G)/ATMdown 2 (CCC CAC TAG TAC
GTG TTT AGA GTT CCC TC). Primers included restriction sites (underlined) for XmaCI, NcoI, SacI,
and SpeI, which were used to combine these fragments with the sulfonamide resistance gene located
on a NcoI/SacI fragment obtained from pUC18/Sul [24] and insert them together into XmaI/SpeI-cut
pBluescript. For PpATR, primer pairs were for 5′ ATRup 1 (GTT CTC ATA TCG ATT TGT GCA TAC
C)/ATRup 2 (AAA GAA TTC CCC AGT AGA ACA ACC TGA AAC) and 3′ ATRdown 1 (GGT AAG
CTT GTG CCA ACG TTT GAT AGT C)/ATRdown 2 (GGG GTC GAC ATT CTC ATT CTT GGG).
These primers included restriction sites for EcoRI, ClaI, HindIII, and SalI, which were used to connect
these fragments to the NPTII gene of pUC18/NPTII [24] located on an EcoRI/HindIII fragment and
insert them into ClaI/SalI-digested pBluescript.
To produce the mutants, plasmids were digested with XmaI/SpeI or ClaI/SalI, which liberated the
targeting fragments. Transformation into P. patens protoplasts and selection of stable transformants
were as described [35]. Transformants were characterized in detail by PCR, Southern blotting (Figure
S1), and flow cytometry, as described in [24,36]. Gene replacement was detected by 5′ and 3′
recombination border fragment-specific standard PCR (Amplicon Taq polymerase, 40 cycles). The 5′
border fragments were detected with primer pairs PpATM_genome_fw (AAC GCC ATC TGT GCA
TTC G)/PpATM/ATR_p35S (AAT TGC CCT TTG GTC TTC TGA G) for ATM and PpATR_genome_fw
(TCG GTT GCT TAC CCT TTG G)/PpATM/ATR_p35S for ATR. The 3′ border fragments were
detected with primer pairs PpATM_tpSul_fwd/PpATM_genome_re (CAG TTC CAG ACC TTA
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ACC TTC ATC) for ATM and PpATR_NPTII_fwd/PpATR_genome_re (AAT GAT GTG GCT GTC
GCT G) for ATR. To detect transformants with precise replacements, we amplified the entire locus
by long template PCR with primer pairs PpATM_genome_fw/PpATM_genome_re for ATM and
PpATR_genome_fw/PpATR_genome_re for ATR and modified or unmodified loci identified by the
size of the fragments obtained. For Southern blots, genomic DNA was digested with StyI for PpATM
and BsoBI for PpATR. Procedures and design (Figure S1) were as described [30]. Probes were obtained
by PCR. The primer combinations were for PpATM: 5′, sATM_5flank_fwd (GGC TTT AGA ACA CTT
GTC CAT)/sATM_5flank_rev (CTC TAG CAC ACC AGC ACT TG); 3′, sATM_3flank_fwd (CTC TTA
CTA TCG GAA TGC TCA G)/sATM_3flank_rev (GTG GAG ACG TTA AGC AAG ATG); deleted part,
sATM_del_fwd2 (GTT GGA CTT GGA GAT CGA) C)/sATM_del_rev (CAT AAC AGA TAG AGT GGC
TTC). For PpATR: 5′, sATR_5flank_fwd (TGT CAT CGA GCA ATA GCC GAA C)/sATR_5flank_rev
(ACC GAG GCA GGG CTT GAA AC); 3′, sATR_3flank_fwd (CAG CGA CAG CCA CAT CAT
T)/sATR_3flank_rev (GCT TAG ATT TAC ATG TGC GAG G); deleted part, sATR_del_fwd (AGG ATG
CCC GTA TGA TGG)/sATR_del_re (CTA GTG AGA GCC CTT TGT CG).
Haploid mutants were selected that had correct 5′ and 3′ recombination junctions, the expected
deletion, and the precise gene replacement. Ppatmatr-1 was obtained in a cross of Ppatm-1 to Ppatr-1 by
selection for both G418 and sulfadiazine resistance, and verification of the cross by PCR.
2.3. Plant Growth Assays
P. patens cultures, procedures, and media were described in detail in Zobell and Reiss [35] and
correspond to common procedures in the P. patens community [21] that we adapted from Schaefer and
Zryd [22]. In particular, the two media used here, minimal and standard medium, an ammonium
tartrate-supplemented minimal medium, correspond in composition to those described by Schaefer
and Zryd [22]. Standard growth conditions were 26 ◦C with continuous white light from the top in
a Percival CU 36L/5D growth cabinet. For growth assays, tissue fragments prepared as for routine
sub-culturing were plated at low density on standard media with cellophane overlay. For assays
on square plates, 7 day old colonies (referred to as micro-colonies) of comparable size were picked
with forceps and transferred in ordered arrays with wild type, Ppatm-1, Ppatr-1, and Ppatmatr-1 in
1 row and 5 replicas in the column to 128 x 128 mm square plates containing standard or minimal
media. Subsequent growth was under standard conditions and monitoring was in 7-day intervals
using a Nikon DS-Fi2-L3 or Leica MZ16 binocular microscope and photography. For direct growth
monitoring, freshly prepared tissue fragments were filtered through a 100-micron sieve to enrich
fragments consisting of 1-3 living cells, were diluted, and were plated on 9 cm Petri dishes containing
standard medium without cellophane overlay. Growth monitoring was as above. Plates were in
duplicate for all experiments, and the data shown are based on three independent experiments.
2.4. DNA Damage Resistance and Checkpoint Control Assays
For the acute assays, protoplasts were isolated as described [35]; were diluted to 20,000 protoplasts
per treatment in standard/mannitol media; had bleomycin or mitomycin C added as indicated in the
figures; were incubated for 1.5 and 16 hours, respectively; were collected by centrifugation; were
washed with standard/mannitol medium; and were processed further as described for protoplast
transformation [35]. Regenerating protoplasts were counted as the colonies obtained after 10 days
in culture. Survival was calculated relative to the mock-treated sample. For the chronic assays,
micro-colonies (wild type, Ppatm-1, Ppatr-1, Ppatmatr-1 and Pprad51AB-1 in one row, 5 replicas per
column) were picked on square plates containing bleomycin, mitomycin C, MMS, methylnitrosourea
(MNU), and hydroxyurea at the concentrations indicated in the figure and grown for 14 (28 for
hydroxyurea) days under standard conditions. Plates were in duplicate and data represent at least
two independent experiments. Concentrations are given in units active substance per liter (u/L) for
bleomycin, in milligrams per liter (mg/l) for mitomycin C, and in millimolars (mM) for the others.
For checkpoint control assays, micro-colonies were transferred to liquid standard medium and incubated
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for 2 hours in the presence and absence of 3 u/L bleomycin, and then 20 µM 5-ethynyl-2′-deoxyuridine
(EDU) was added and culturing continued under constant shaking for an additional 6 hours.
Processing was as described in the manufacturer’s instructions (Click-iT EDU Alexa Fluor 488 Imaging
Kit, Molecular Probes/Invitrogen). In brief, colonies were fixed, EDU was coupled to Alexa488 Fluor
to visualize replicated cells, and nuclei were counter-stained with 4′,6-Diamidine-2′-phenylindole
dihydrochloride (DAPI). DAPI counterstained and Alexa488 Fluor-stained tip cells were counted by
fluorescence microscopy, and the data were normalized to the DAPI-stained nuclei and plotted.
2.5. Compilation of DNA Damage Repair-Related and ATM- and ATR-Interacting Genes from A. thaliana and
P. patens
Genes involved in DNA damage repair were compiled from published datasets described for
yeast [37] and human [38], their protein sequences were retrieved from the ENA/GenBank and UniProt
databases, and the collection was updated and complemented with ATM- and ATR-interacting genes.
The same databases were used to retrieve the corresponding A. thaliana orthologues by BLASTP
searches using the yeast and human protein sequences as query. This collection was complemented
with plant-specific recombination genes retrieved from TAIR (www.arabidopsis.org) and redundancy
caused by nomenclature differences between organisms was removed. The collection of 186 different
genes obtained this way is presented in Table S1. To identify the corresponding genes in the P. patens
genome, we BLASTed the entire collection of DNA repair genes comprising all the yeast, human, and A.
thaliana protein sequences against the version 1.6 gene models, which was available at CosMoss.org at
that time, and through using the tools this site provided. The corresponding hits were manually curated
and ambiguities were resolved with additional BLAST analyses in the NCBI and UniProt databases
using unclear sequences as query. Remaining uncertainties in ontology were clarified by phylogenetic
analyses in representative species and unambiguous genes were listed individually, or otherwise they
were grouped together. This analysis resulted in a collection of 120 different genes with functions
related to DNA repair that are present in P. patens (Table S1). These are represented by 188 different
sequences due to the gene duplications existing in the P. patens genome. A free tool for the conversion
of the v1.6 to the v3.3 P. patens genome annotation is available at http://plantco.de/research.php.
2.6. SuperSAGE and Transcriptomics
To obtain synchronous, actively growing cultures, we passaged stocks 3 times on standard medium
with cellophane overlay by routine sub-culturing with 10 plates, each grown under exactly identical
conditions, i.e., in parallel and in the same shelf in the same growth cabinet. Material was pooled,
sub-cultured again on 10 plates with standard medium and cellophane overlay for 5 days, harvested,
and pooled again. For the analysis of the transcriptional response of wild type to bleomycin, an aliquot
(approximately 1 gram wet weight) was treated for 1 hour with 0, 0.3, and 3.0 units/liter (u/L) bleomycin
in 10 ml liquid standard medium in a 50 ml Falkon tube before RNA was prepared. An additional
aliquot of the 0.3 u/L treatment was washed free of bleomycin by filtering through a nylon mesh,
washing with water, and incubated for additional 3 hours in 20 ml standard medium in a 9 cm Petri dish
before RNA was prepared immediately thereafter. For the mutant analysis, wild type, Ppatm-1, Ppatr-1,
and Ppatmatr-1 cultures were prepared as described above and the material pooled. Mock-treatment
and treatment with 0.3 u/L bleomycin was with an aliquot (approximately 5 gram) by incubation in
300 ml liquid standard media in a 500 ml Duran bottle followed by removal of bleomycin by filtering
and washing and an additional 3 hour incubation in fresh standard medium before RNA was prepared
immediately thereafter. Preparation of total RNA was as described [39]. SuperSAGE analysis and
data processing were performed by GenXPro (Frankfurt, Germany), as described in [40,41]. In brief,
libraries were prepared and were sequenced using Illumina technology, tag counts were normalized
to tags per million, the corresponding P. patens transcripts were identified by BLAST searches in the
version 1.6 release gene models [42], and the corresponding transcript abundance frequencies were
calculated. For the whole genome analysis, transcript abundance frequencies were processed with
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ArrayStar (Lasergene DNASTAR Bioinformatics software suite) using default parameter settings.
For the collection of DNA repair genes, we pooled non-identical gene models hit by the same tag
sequence in families, aggregated tag counts within the same gene, and excluded ambiguous data
and genes represented with less than 10 tags. Finally, transcript abundance frequencies were used to
calculate abundance ratios between wild type and mutants, and induced and non-induced conditions.
2.7. Gene Targeting Assays
Gene targeting assays were as described [30]. Wild type, Ppatm-1, Ppatr-1, and Ppatmatr-1
protoplasts were transformed in single experiments in parallel. Detection of gene targeting was by PCR,
and transformants with at least one correct 5′ or 3′ recombination junction were counted as positive.
The data are the mean of 7 independent experiments. Differentiation between gene replacement,
one-sided integration, and ectopic targeting was performed by PCR with a representative subset.
2.8. Accession Numbers
Sequence data from this article can be found in the ENA/GenBank data libraries under accession
numbers LT999877 (PpATM, Pp3c2_23700V3.1) and LT999878 (PpATR, Pp3c6_3460V3.1). The original
SuperSage data consisting of tag sequences together with associated tag frequency counts are available
at ArrayExpress under accession number E-MTAB-9082.
3. Results
3.1. The P. patens ATM and ATR Orthologues, Gene Structure, and Production of Mutants
The identification of ATM and ATR is described in detail in the Materials and Methods section
and it was essentially confirmed that the gene models in the latest P. patens chromosome-scale assembly,
Pp3c2_23700V3.1 (PpATM) and Pp3c6_3460V3.1 (PpATR) [33], are the correct P. patens orthologues.
Our analysis also confirmed the described gene structures (Figure 1A), except for the extreme 5′ and 3′
ends of the predicted transcripts. The corresponding transcript sequences are available at ENA/GenBank.
ATM and ATR proteins are well conserved in the three FAT, PI3K, and FAT-C domains
characterizing the PIKK family proteins, but have diverged over larger evolutionary distances. To show
their correct affiliation and position within the bryophytes and the general plant kingdom, we selected
representative ATM and ATR protein sequences from organisms with functionally characterized genes,
except for plants, where A. thaliana is the only representative and their phylogenies were established
(Figure 1B). This analysis confirmed the identity and phylogenetic position of PpATM and PpATR and
confirmed a generally lower degree of conservation of ATM as compared to ATR between organisms.
The PI3K domain is essential for function in mammalian genes [43–45]. To obtain non-functional
ATM and ATR variants, we deleted the genomic regions encoding PI3K and FAT-C domains by targeted
gene replacement and exchanged them for two different resistance genes (Figure 1A). The ATM
domain replacement mutant was obtained by constructing a targeting vector (described in detail in the
Materials and Methods section), which removed the last six exons from the PpATM gene and replaced
it with a sulfonamide resistance gene [24]. The PpATR targeting vector was constructed to remove
the last three exons from PpATR and replace it with the G418 resistance-conferring NPTII gene [24].
Protoplasts were transformed with the corresponding targeting vectors using standard methods [22],
and transformants were selected and characterized. Detailed PCR and Southern blotting analyses
described in the Materials and Methods section were used to identify individuals with correct 5′ and 3′
recombination junctions in which the intended genomic segments were deleted and precisely replaced
with the marker genes. The results are shown in Figure S1. Three independent domain replacement
mutants were selected—Ppatm-1, Ppatm-2, Ppatm-3 and Ppatr-1, Ppatr-2, Ppatr-3—which were verified
to be haploid by flow cytometry (Figure S2). The Ppatmatr-1 double mutant was obtained by crossing
Ppatm-1 and Ppatr-1 and selection of the resulting spores for resistance to both G418 and sulfadiazine.
The presence of both mutations in the double mutant was verified by PCR.
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Figure 1. Phylogenetic analysis, gene structure, and targeted replacements. (A) The structure of PpATM
and PpATR genes is shown with exons indicated in light gray and the conserved FAT, PI3-4 kinase,
and FAT-C domains in color. The domain replacements obtained by gene targeting are shown below.
Abbreviations: P35S, CaMV 35S promoter; G148R, NPTII gene conferring G418 resistance; SULR,
sulfadiazine resistance gene. (B) Phylogenetic tree of ataxia-telangiectasia-mutated (ATM) and ATM
and Rad3-related (ATR) proteins of representative lineages including mammals (Hs, Homo sapiens;
Mm, Mus musculus), insects (Dm, Drosophila melanogaster), yeasts (Sc, Saccharomyces cerevisiae; Sp,
Schizosaccharomyces pombe), flowering plants (At, Arabidopsis thaliana; Os, Oryza sativa), and bryophytes
(Pp, Physcomitrella patens; Spf, Sphagnum fallax). Bootstrap values are shown.
3.2. ATM and ATR are Important for Vegetative Development
An illustration of the complete P. patens life cycle is shown in Figure S3, and detailed background
information on this organism is available in several reviews [19–21,46]. In brief, P. patens has a dominant
gametophytic, haploid generation with distinct juvenile and adult phases. The former is characterized
by two-dimensional growth of protonema, a tissue consisting of two types of filaments: chloronema
and caulonema. Outgrowth from a spore or regeneration of tissue begins with the formation of
slower-growing chloroplast-rich chloronemata, followed by a gradual transition to faster-growing
caulonemata. Side branch formation generates secondary chloronemata and also the bud initials that
develop into gametophores, the leafy shoots of the moss plant, at the beginning of the adult phase.
Thus, the later stages are characterized by a mixture of protonemal and gametophore growth, both of
which determine colony morphology and circumference.
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To observe vegetative development, 7 day old micro-colonies obtained by sub-culturing of
protonema fragments were picked on square plates containing either minimal or standard medium,
as well as an ammonium tartrate supplemented minimal medium, and were propagated to the early
adult phase. Colony growth of wild-type (wt) and the Ppatm-1, Ppatr-1, and Ppatmatr-1 mutants
cultured side-by-side on the same plate was monitored at 7-day intervals by direct observation and
photography (Figure 2A). Additionally, tissue fragments were plated directly on media in standard Petri
dishes and growth was monitored in a similar manner (Figure S4). Ppatm-1 colonies on square plates
with standard medium differed from wild type in morphology and size from the 14 day time point on.
At this stage, caulonemal filaments protruded from the center in the mutant whereas wild type colonies
showed more compact central gametophore formation with peripheral protonemata. Regeneration of
directly plated tissue fragments showed that caulonemal development was stimulated at the earliest
stages of filament regeneration in the Ppatm-1 mutant. Consequently, the gametophores (Figure 2A)
preferentially developing along caulonemata were spread evenly across the surface of the colony in the
mutant while their growth was restricted to the center in wild type. Ppatr-1 mutants initially showed
apparently normal growth (Figure 2A), but the chloronema to caulonema transition and branching was
noticeably inhibited (Figure S4A). The phenotype became macroscopically visible after the switch from
protonema to gametophore development. Gametophore development was severely disrupted, with
most bud initials developing into callus-like structures or largely reduced shoot-like structures that
gradually degenerated (Figure 2B and Figure S4A). Moreover, filaments rapidly turned brown, a typical
feature of ageing [46], which spread throughout the entire colony at later stages. Tissue browning
commenced at the beginning of gametophore growth, but is unlikely to be a direct result of growth
inhibition [47], suggesting that ATR loss causes this premature ageing phenotype. Thus, ATR became
essential for viability following the switch from two- to three-dimensional growth, equivalent with the
development of morphologically more complex structures. The phenotype of the Ppatmatr-1 double
mutant closely resembled that of Ppatr-1, but was more severe, with growth rate further restricted and
gametophore development being almost entirely abolished.
The three independently isolated mutants, Ppatm-1, -2, and -3, and Ppatr-1, -2 and -3 (Figure S4B),
showed consistently identical growth phenotypes, indicating that the observed phenotypes resulted
from the mutations introduced by the respective domain replacements in the corresponding genes.
Cultures on standard or minimal medium differ in colony morphology and growth rate. Wild type
on minimal medium formed smaller colonies but showed enhanced caulonemal development
(Figure 2A).This effect was mainly due to the absence of ammonium tartrate in this medium that allows
unrestricted caulonema growth and reduces growth rate [19,46]. Considering the altered growth
characteristics on this medium, the Ppatm-1 phenotype remained unchanged, but increased caulonemal
growth rate led to larger colonies and early gametophore development. In the Ppatr-1 mutant,
the defects in protonemal development were also more pronounced, but principally remained
the same. However, later, colonies showed no signs of premature ageing and gametophores did
develop (Figure 2B), albeit frequently with aberrant morphology. Since caulonemal development was
largely inhibited in Ppatr-1, the higher growth rates obtained on standard medium likely caused the
browning of colonies and inhibition of gametophore growth. The Ppatmatr-1 double mutant appeared
similar to the Ppatr-1 mutant, but the phenotype was more severe and gametophores were virtually
absent. The gradual increase in severity of Ppatr-1 phenotypes from minimal to standard medium
to the Ppatmatr-1 double mutant on the same media suggests that the growth-promoting component
contributed by the Ppatm-1 mutant caused the increase in severity of the phenotype. In addition,
incubation under light and temperature conditions that reduced growth rate altered or alleviated
the observed phenotypes (Figure S5). This suggests that the importance of ATR for viability and
development of more complex morphological structures may critically depend on cell proliferation
rate, and the data show that growth conditions critically impact the expressivity of mutant phenotypes.
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Figure 2. Developmental phenotypes of Ppatm-1, Ppatr-1, and Ppatmatr-1 mutants under different growth
conditions. (A) The pictures show colony growth after transfer of micro-colonies in ordered arrays to
standard (left panel) and minimal (right panel) medium under standard conditions. Pictures show
colonies after 7 (row 1), 14 (row 2), 21 (row 3), and 28 (row 4) days of growth. (B) Magnification of
colonies in row 4 showing details in colony morphology and gametophore development. Bars = 1 cm.
Ppatm-1 plants were fully fertile, and gametophores, gametangia, and the sporophyte developed
normally (Figure S6), suggesting that ATM plays no role in gametogenesis, fertilization, sporophyte
development, and meiosis. Conversely, Ppatr-1 plants were mostly sterile, with mature gametophores
bearing almost no spore capsules, although archegonia and antheridia (the female and male reproductive
organs) were produced. However, archegonia were either mostly defective or aborted prematurely,
possibly after fertilization had occurred, while antheridia appeared normal (Figure S6) and were
clearly able to produce viable spermatozoids, as demonstrated by the productive cross to Ppatm-1
to obtain the double mutant. Thus the ATR mutation became progressively irreversibly lethal with
the onset of sporophyte development throughout reproductive development. The Ppatmatr-1 mutant
was even more defective, and both archegonia and antheridia on the few shoots that developed were
morphologically aberrant (Figure S6) with no sporophytes being formed.
3.3. ATR Dominates DNA Damage Repair and Checkpoint Control
We used chronic and acute exposure to different genotoxins to analyze the role of ATM and ATR
in DNA damage repair. These chemicals induce a spectrum of damages that are specific for each
substance, but all of them finally induce DSBs. The radiomimetic bleomycin causes DSBs directly
(direct DSBs), whereas the lesions induced by the others (mitomycin C, MMS, MNU, and hydroxyurea)
are processed to DSBs during replication (replication-coupled DSBs). In acute assays, protoplasts were
pulse-treated with increasing concentrations of bleomycin or mitomycin C, were allowed to recover in
the absence of the drugs, and had the survivors scored. This assay (Figure 3A) showed that both wild
type and Ppatm-1 mutants were equally resistant to bleomycin and mitomycin C while both Ppatr-1
and Ppatmatr-1 mutants were highly sensitive. Additionally, the survival curve indicated that all DNA
repair capacity was lost in these two mutants. Thus, ATM contributed neither to the repair of direct nor
replication-coupled DSBs or other DNA damage under these conditions, whereas ATR alone mediated
recovery from DNA damage including both types of DSBs. Complete abolition of RAD51 activity in
the Pprad51AB-1 double mutant [24] caused the same degree of sensitivity to bleomycin as Ppatr-1
and Ppatmatr-1, suggesting that repair of direct DSBs is by an HR pathway regulated by ATR.
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However, the Pprad51AB-1 double mutant was only partially sensitive to mitomycin C, suggesting
that lethality was not exclusively caused by replication-coupled DSBs, but that other forms of DNA
damage played a role also or that RAD51-mediated HR plays a limited role in replication-coupled DSB
repair in P. patens, in contrast to A. thaliana [24]. Notwithstanding this difference, the Ppatr-1 survival
curve indicated that all DNA damage repair depended on ATR.
Figure 3. DNA damage resistance and checkpoint control assays. (A) Acute assays. The survival curves
for wild type and Ppatm-1, Ppatr-1, Ppatmatr-1, and Pprad51AB-1 mutants calculated as a percentage
relative to the mock treatment are shown in log [10] scale. Data are the mean (n = 2) +/- SD. (B) Chronic
assays. The pictures show colonies after 14 (28 for hydroxyurea) days of growth in the presence
of the indicated concentrations of genotoxins under standard conditions. (C) Checkpoint control
assays. The graph shows the number of replicated (Alexa488-fluorescent) cells as the percentage of the
total number of stainable (DAPI-positive) cells in 20 independent colonies in mock (untreated) and
bleomycin-treated (bleomycin) plants. Data are the mean (n = 3) +/- SD. Concentrations are in units
active substance per liter (u/L), milligrams per liter (mg/l), or millimolars (mM).
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In the chronic assays, micro-colonies were inoculated on square plates containing increasing
concentrations of bleomycin, mitomycin C, MMS, MNU, or hydroxyurea, and colony growth and
morphology scored as a measure of resistance. This assay (Figure 3B) largely recapitulated the results
of the acute assay, except that Ppatm-1 mutants grew noticeably more slowly than wild type at the
highest concentrations of bleomycin and the Ppatmatr-1 double mutant also appeared more sensitive
than Ppatr-1. At these concentrations, Ppatm-1 colonies arrested growth with reduced caulonemal
production, but remained green and viable, like the wild type. This is a mild but noticeable sensitivity
to bleomycin in actively growing tissue, predominantly causing growth arrest but not immediate
lethality. By contrast, Ppatr-1 and Ppatmatr-1 mutants showed early growth arrest and lethality with
increasing bleomycin and mitomycin C concentrations, suggesting that ATR is essential for resisting
DNA damage and sustained viability alike. These data suggest that ATM has a minor function in the
repair of direct DSBs and other damage that is restricted to actively and continuously proliferating cells.
All mutants showed a similar pattern of sensitivity to mitomycin C, hydroxyurea, MMS, and MNU,
with only the Ppatr-1 and Ppatmatr-1 mutants exhibiting significant hypersensitivity. These chemicals
cause either inter-strand crosslinks (mitomycin C) or alkylate DNA (MMS and MNU), or directly
interfere with replication (hydroxyurea) and have a common outcome in inducing replication-coupled
DSBs, either indirectly by conversion of pre-existing lesions to DSBs or directly by causing replication
errors. A problem with these assays is the prolonged incubation time and chemical instability of some
chemicals (MNU, bleomycin) that causes decay of activity over time such that the material is not
exposed to identical concentrations all the time. Nevertheless, the similarity of the results obtained with
these chemicals suggests that this problem has limited influence on the performance of such assays.
In addition, the similarity in resistance patterns suggests that the lethality inducing lesions limiting
survival under these conditions are predominantly replication-coupled DSBs, although the other DNA
damage induced by these chemicals clearly requires repair also. Therefore, identical sensitivity to all
four chemicals predominantly reflects the different requirements for ATM and ATR in the repair of
replication-coupled DSBs, but does not exclude the participation of ATR in the control of other repair
pathways dealing with the DNA damage induced by these chemicals also.
ATM and ATR have a highly conserved function as cell-cycle checkpoint control kinases. This role
was analyzed by monitoring replication in protonemal tip cells immediately following exposure
to bleomycin, using EDU incorporation and identification of replicating cells [48] by fluorescence
microscopy after a short interval (Figure 3C). In the mock-treated sample, the same number of wild type
and mutant cells went through replication in this interval, indicating that none of them had a noticeable
inherent cell-cycle defect, consistent with the wild type-like flow cytometric histograms obtained with
the mutants (Figure S2). Replication in this interval was 97% inhibited in wild type after exposure to
bleomycin, showing successful checkpoint activation and cell-cycle arrest in response to DNA damage.
This number dropped to 3% and 2% inhibition for Ppatr-1 and Ppatmatr-1, respectively, and the majority
proceeded through replication, indicating a significant loss of checkpoint control. In Ppatm-1, 81% of
the cells remained arrested in replication, indicating that checkpoint control remained largely intact.
Nevertheless, the proportion proceeding through replication was notably higher than in wild type,
in agreement with the observed mild bleomycin sensitivity of Ppatm-1 in proliferating cells.
3.4. The Role of ATM and ATR in Gene Targeting
Gene targeting assays were performed with the PpCOL2 gene as a target, as described
previously [30]. Transformation of Ppatm-1 yielded significantly more transformants than wild
type (Figure 4A) and the absolute number of gene-targeting events per experiment seemed to be
reduced to half the number obtained in wild type (Figure 4B). The PpATR-1 mutation caused a moderate
increase in transformation efficiency, but seemed to have no effect on gene targeting. However, gene
targeting efficiencies almost dropped below detection levels in the Ppatmatr-1 double mutant, whereas
transformation efficiencies were only mildly affected, if at all. HR-mediated DNA integration processes
in P. patens produce three different outcomes, gene replacement, one-sided integration, and ectopic
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targeting (as explained in [30]), together referred to as gene targeting here. An analysis differentiating
between these events showed that they also occur in the mutants. The proportions as they occurred in
wild type remained the same in Ppatm-1, but were shifted from ectopic targeting to gene replacement
in Ppatr-1 and possibly Ppatmatr-1 also (Figure 4C). This shift indicated an increase in HR-mediated
integration of recombination intermediates into the genome and suggests that ATR plays a role in
the control of gene targeting after the initiation step. Together, the data suggest that both genes play
an unexpected role in the integration of foreign DNA, with ATM being significantly more important
than ATR. However, individually both of them have limited importance for gene targeting, with ATM
possibly being involved in the initiation step and ATR in the processivity of the process.
Figure 4. Gene targeting assays. (A) The graph shows the number of stable transformants normalized
to transformants per 10,000 regenerating protoplasts. The data are the mean of seven independent
experiments +/- SD. (B) Proportion of gene targeting and random integration events in wild type
and the mutants as determined by 5′ and 3′ recombination junction-specific PCR in a representative
subset of transformants. The data are the mean +/- SD. (C) Relative proportions of gene replacement,
one-sided integration, and ectopic targeting in wild type and the mutants, as determined by PCR.
Genes 2020, 11, 752 13 of 25
3.5. The Importance of ATM and ATR in the Transcriptional Response to Bleomycin-Induced Damage
To analyze the early phase of the transcriptional response to bleomycin-induced damage and its
dependence on the severity of the damage, we used exposure for 1 hour to a sub-lethal (0.3 u/L) and a
lethal (3 u/L) dose of bleomycin. In addition, an aliquot of the 0.3 u/L treatment was washed free of
bleomycin and incubated for an additional 3 hours in its absence. Thereafter total RNA was prepared
and transcriptional patterns were determined by SuperSAGE [49,50]. The original SuperSAGE data
comprising tag sequences and associated tag frequencies are available in ArrayExpress. Mapping of
tag sequences to P. patens v1.6 transcripts [42] showed that a 1 hour treatment with a sub-lethal
concentration was sufficient to induce massive changes in expression (Figure 5A). Exposure to the
lethal dose provoked an apparently rather similar response. A significantly larger number of genes
appeared to be differentially expressed after the 3 hour period following the sub-lethal dose in the
absence of bleomycin, but the mock treatment used as reference here was the untreated 1 hour control
experiment used for all treatments in this series. Therefore, and as suggested by a comparison with
the experiment using identical reference points below (Figure 5C) the treatment procedure alone
likely contributed to the increase in differential expression. Consequently, the data in this experiment
comprise transcripts of genes responsive to bleomycin-induced damage, which changed in expression
within the recovery period and those of stress-responsive genes that react to the treatment.
To analyze the involvement of ATM and ATR in the transcriptional response to DNA damage,
we chose the 1 hour bleomycin treatment followed by the 3 hour recovery period. For this analysis,
wild type and the Ppatm-1, Ppatr-1, and Ppatmatr-1 mutants were cultivated under identical conditions;
material from independent plates were pooled, pulse-treated, or mock-treated for 1 hour with 0.3 u/L
bleomycin; and total RNA was prepared after the 3 hour recovery period that followed. The SuperSAGE
analysis was as described above and the original data are available in ArrayExpress also. The expression
profiles (Figure 5B) obtained in the absence of bleomycin-induced DNA damage differed between wild
type and the mutants and between them. In this comparison, the double mutant was the one exhibiting
most of the changes, displaying a substantial fraction of upregulated transcripts, suggesting that ATM
and ATR synergistically control transcript homeostasis of a large number of genes, a substantial fraction
of which may comprise treatment stress-responsive genes differentially expressed in the mutants.
A substantial number of transcripts responded to the DNA damage induced by bleomycin in wild
type (Figure 5C). This response is noticeably affected in the mutants and fewer transcripts responded
in the Ppatm-1 and Ppatr-1 mutants, or expression changes were lower. The Ppatmatr-1 double mutant
stood out by showing a markedly different expression pattern, which was almost a mirror image of the
pattern found in the absence of DNA damage before (Figure 5B). The noticeable differences between
the single and the double mutants suggest that the response to bleomycin-induced DNA damage
is synergistically coordinated by ATM and ATR also. However, the changes in expression between
different conditions and the mutants and wild type by far exceeded the number of known DNA repair
genes, suggesting that many of them reflect secondary effects not directly related to DNA damage
repair or general stress responses.
To focus on the analysis of DNA repair functions and ATM and ATR interacting proteins,
we collected the genes involved in these processes in yeast (Saccharomyces cerevisiae) [37] and human [38]
and retrieved the corresponding orthologues in P. patens and A. thaliana, as described in the Materials
and Methods section. This collection is shown in Table S1. The transcript abundance ratios between
wild type and mutants and induced and non-induced conditions were calculated from the SuperSAGE
data for the genes in this set and are presented in Table 1. The corresponding data for the different
bleomycin induction conditions in wild type are shown in Table S2. All mutants showed differences in
their expression profiles to wild type in the absence of bleomycin-induced DNA damage (Table 1).
However, only a few genes were altered in expression in Ppatm-1, while the changes in Ppatr-1 and
Ppatmatr-1 were more substantial. In addition, the Ppatmatr-1 profile shows only few similarities to
either single mutant.
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Figure 5. Whole transcriptome SuperSAGE analysis. (A) Whole transcriptome analysis of the early
response to bleomycin-induced DNA damage. The results of the treatment and mock treatment,
respectively, of wild type with lethal (3.0 u/L) and sub-lethal (0.3 u/L) concentrations of bleomycin for
1 hour and the following 3 hour recovery period are shown. The SuperSAGE tags were mapped to P.
patens transcripts and had their data normalized, and fold change ratios for the 15561 transcripts in the
analysis were calculated. The scatter plots show the following comparisons: 1 h bleomycin 0.3, mock
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treatment for 1 h (T1/0, x-axis) versus 1 h 0.3 u/L treatment (T1/0.3, y-axis)); 1 h bleomycin 3.0, mock
treatment for 1 h (T1/0, x-axis) versus 1 h 3.0 u/L treatment (T1/3.0, y-axis)); 1 h bleomycin 0.3 + 3 h, mock
treatment for 1 h (T1/0, x-axis) versus 1 hour 0.3 u/L treatment followed by 3 h recovery (T4/0.3, y-axis).
(B,C) Whole transcriptome analysis of mutants in the absence and presence of bleomycin-induced DNA
damage. Wild type and Ppatm-1, Ppatr-1, and Ppatmatr-1 mutants were treated and mock-treated with
a sub-lethal (0.3 u/L) concentration of bleomycin for 1 h followed by a 3 h recovery period, and fold
change ratios were calculated from normalized SuperSAGE tags mapped to P. patens transcripts as
above. (B) The scatter plots show mutant to wild type comparison in the absence of bleomycin-induced
DNA damage. Ppatm-1 – wild-type (wt): wt mock-treated (wt0, x-axis) versus Ppatm-1 mock-treated
(ATM0, y-axis), Ppatr-1– wt: wt mock-treated (wt0, x-axis) versus Ppatr-1 mock-treated (ATR0, y-axis),
Ppatmatr-1 – wt: wt mock-treated (wt0, x-axis) versus Ppatmatr-1 mock-treated (ATMATR0, y-axis).
(C) The scatter plots show the comparisons of mock- to bleomycin-induced DNA damage for wild type
and mutants. wt: 0.3 – 0: wt mock-treated (wt0, x-axis) versus treated with 0.3 u/L bleomycin (wt0.3,
y-axis), Ppatm-1: 0.3 – 0: mutant mock-treated (ATM0, x-axis) versus treated with 0.3 u/L bleomycin
(ATM0.3, y-axis), Ppatr-1: 0.3 – 0: mutant mock-treated (ATR0, x-axis) versus treated with 0.3 u/L
bleomycin (ATR0.3, y-axis), Ppatmatr-1: 0.3 – 0: mutant mock-treated (ATMATR0, x-axis) versus mutant
treated with 0.3 u/L bleomycin (ATMATR0.3, y-axis). Axes are in log2 scale. The purple broken line is
the linear regression. The border limits of twofold changes are marked with green lines. Data points
with fourfold or more differences between conditions are marked in white. Top and bottom data points
are in red and blue, respectively.
Bleomycin treatment induced massive alterations in the expression profiles in this set. The most
interesting genes induced in wild type were early responding DNA damage repair activities and
components of the two major DSB repair pathways, HR and NHEJ (Table 1 and Table S2). One of the
early induced activities was the 9-1-1 complex. This complex is involved in early steps of DSB repair;
consists of hRAD1, HUS1, and RAD9A; and plays a prominent role in damage recognition and in
recruitment of repair proteins to the damaged site [51,52]. All of these genes, including the RAD17
gene whose activity loads the complex onto DNA, were induced, albeit to different levels. PARP family
proteins were also among the activities early responding to DNA damage, having DNA break-sensing
and signaling activities involved in multiple repair pathways [53]. One of them, PARP2, the gene
functionally important in A. thaliana [54], was also noticeably induced. Of the two main DSB repair
pathways, the key players in HR—RAD51, RAD54, and RAD54B—and in classical NHEJ—KU70 and
KU80—were induced. In addition, many if not all other DNA repair pathways were also induced
(Table 1 and Table S2). Among these were genes with general functions such as processing of “dirty”
DSBs (PNKP) and sealing of a DSB (XRCC4), or activities mediating interaction with chromatin (SMC6)
and activation of cell-cycle checkpoints (MDC1). These are largely the same principal activities that
were described as being induced by a 24 hour bleomycin treatment previously [55].
The response in the Ppatm-1 mutant was rather similar to wild type (Table 1). In particular, genes
encoding components of the 9-1-1 complex (HUS1, RAD9A), PARP2, and the two main DSB repair
pathways remained inducible, although their expression levels changed. In addition, expression levels
of other genes also changed (Table 1), showing that ATM is relevant, but likely plays only a minor role
in the control of direct DSB repair. By contrast, upregulation of the early responding activities and DSB
repair pathways was noticeably more defective in the Ppatr-1 mutant, and additionally expression of
many more genes was affected (Table 1). The Ppatmatr-1 mutant was noticeably different from any of
the single mutants. Induction of almost all genes failed, and expression levels above the un-induced
state were mostly elevated basal levels. This pattern confirms the complexity of the roles of ATM and
ATR in the DDR and stresses their tight interaction and synergistic relationship in the transcriptional
regulation of the DDR.
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Table 1. DNA damage repair gene-specific differential expression profiles.




wt Ppatm-1 Ppatr-1 Ppatmatr-1









Checkpoints, Regulators, and Signaling
ATRIP 0.8 0.9 0.5 0.6 0.8 0.8 1.0 1.0 0.9 0.8
ATRX 1.4 1.3 3.0 2.3 1.2 1.4 1.1 2.2 2.2 1.0
hRAD1/REC1 0.6 0.6 0.4 0.7 0.4 0.6 1.6 0.4 0.4 0.9
Hus1 2.6 0.7 3.8 5.1 1.8 1.2 0.7 2.0 1.8 0.9
MAPK family 1.5 0.9 0.6 0.7 1.0 1.2 1.1 1.2 1.6 1.3
MDC1 2.6 0.6 1.9 3.0 2.0 1.6 0.8 3.8 2.1 0.6
PARP2 6.0 0.8 2.6 3.5 1.0 1.2 1.2 3.0 0.7 0.3
PMYT1 0.6 1.0 0.9 0.8 1.0 1.0 1.1 1.2 0.9 0.8
RAD17 2.2 1.4 1.5 1.1 1.7 1.7 1.0 1.6 1.7 1.1
RAD9A/Sprad9 21.0 0.4 10.4 27.6 2.6 2.4 0.9 4.7 2.3 0.5
WEE1 0.9 0.7 0.9 1.4 1.1 1.7 1.5 0.7 1.1 1.7
Homologous Recombination and Meiosis
HOP2 0.9 0.8 0.8 1.0 0.7 0.9 1.2 0.9 0.9 1.1
MUS81 0.3 0.7 0.2 0.3 0.3 0.2 0.6 0.8 0.6 0.8
NBN 0.8 1.0 0.7 0.6 0.7 0.7 1.0 0.7 0.6 0.9
PaxIP1 (1) 0.8 0.8 0.7 0.8 1.0 0.8 0.9 1.8 0.8 0.4
PaxIP1 (2) 3.1 1.6 0.7 0.4 0.5 2.4 4.5 3.0 0.5 0.2
PaxIP1 (3) 0.5 0.7 0.7 1.0 0.9 0.6 0.6 1.1 1.0 0.9
RA51B 0.4 1.0 1.0 1.0 1.4 1.5 1.0 0.9 1.4 1.6
RA51C 1.8 0.7 0.8 1.0 1.3 1.6 1.2 1.2 1.3 1.1
RA54B 2.8 0.7 2.9 4.2 0.8 1.5 1.9 1.2 1.1 0.9
RAD50 0.7 1.6 1.5 1.0 0.7 1.2 1.6 1.3 1.0 0.8
PpRAD51A 5.2 0.9 5.4 6.0 0.8 2.1 2.7 1.5 1.7 1.1
PpRAD51B 1.0 0.5 1.9 3.8 1.7 1.2 0.7 1.7 1.2 0.7
RAD54 (1) 2.8 0.7 3.5 4.9 1.4 1.6 1.2 2.1 2.2 1.0
RAD54 (2) 0.5 1.3 0.8 0.6 0.5 0.7 1.4 1.5 1.5 1.0
RMI2 1.4 0.9 2.2 2.4 1.4 1.6 1.2 1.4 1.8 1.3
RQSIM 1.4 0.8 1.4 1.8 0.9 1.8 2.0 1.5 1.5 1.0
SPO11 2.2 1.5 2.6 1.8 2.9 2.0 0.7 1.9 3.5 1.8
TOP3B 0.2 0.6 0.8 1.3 1.0 1.3 1.4 0.5 1.0 1.8
WRIP1 (1) 2.1 0.6 1.7 3.0 2.3 0.7 0.3 1.9 1.7 0.9
WRIP1 (2) 0.5 0.3 0.3 1.1 0.6 0.7 1.3 0.7 0.5 0.7
WRX (1) 1.3 1.1 1.5 1.4 3.3 2.1 0.6 3.0 1.7 0.6
WRX (2) 1.2 1.1 1.6 1.5 2.2 1.0 0.4 1.9 1.2 0.6
XRCC2 0.7 0.6 0.9 1.6 0.7 0.9 1.2 1.6 1.5 1.0
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Table 1. Cont.




wt Ppatm-1 Ppatr-1 Ppatmatr-1









General Functions and Crosslink Repair
DNL1 1.5 1.0 0.9 0.8 0.6 0.8 1.4 0.8 0.8 0.9
FANCL 1.0 1.0 0.5 0.5 0.7 0.5 0.8 0.8 0.8 1.0
PIF1 2.8 1.3 1.5 1.1 1.9 1.1 0.6 2.4 2.6 1.1
PNKP 4.6 0.5 5.5 10.6 0.4 1.3 3.3 2.7 2.9 1.1
RAD21 0.5 0.7 1.1 1.5 0.5 0.8 1.5 0.7 0.5 0.7
RNF4 (1) 1.0 0.7 0.7 0.9 0.4 0.4 0.9 0.7 0.7 0.9
RNF4 (2) 1.1 1.4 1.5 1.1 1.3 1.1 0.8 2.9 1.6 0.5
RNF4 (3) 0.8 0.8 0.7 0.8 0.6 0.7 1.1 0.9 1.1 1.2
RUVBL1 0.4 1.6 1.4 0.9 0.9 0.4 0.5 1.3 1.2 0.9
RUVBL2 0.4 1.0 0.6 0.6 0.7 0.9 1.4 0.6 0.9 1.6
SCC2 0.6 1.4 1.1 0.8 0.7 0.9 1.3 1.0 0.8 0.8
SMC1A 1.3 0.9 1.6 1.8 2.1 1.4 0.6 1.5 1.2 0.8
SMC3 1.1 1.0 1.2 1.3 1.7 1.6 0.9 1.3 0.9 0.6
SMC5 0.6 0.7 0.6 0.9 0.7 0.9 1.2 0.7 0.7 0.9
SMC6 3.5 0.4 3.9 8.8 1.3 0.8 0.6 1.7 0.4 0.2
STAG1 1.3 0.5 1.3 2.5 0.4 1.0 2.4 1.2 0.6 0.5
Non-Homologous End-Joining
KU70/XRCC6 7.8 0.8 3.6 4.5 0.9 2.3 2.6 2.8 1.1 0.4
KU80/XRCC5 5.3 0.9 4.3 4.8 2.5 2.3 0.9 3.8 3.3 0.9
PRKDC 0.9 1.3 1.3 1.0 0.9 0.9 1.1 0.5 0.4 0.8
XRCC1 0.8 1.0 0.8 0.8 0.8 0.6 0.7 1.4 0.4 0.3
XRCC4 5.1 0.2 2.5 11.1 0.3 1.2 4.8 0.4 0.7 1.6
Mismatch Repair
EME1 0.6 1.3 1.6 1.2 2.3 3.0 1.3 1.4 3.0 2.1
EXO1 1.2 1.0 1.3 1.4 1.4 1.6 1.2 1.3 1.5 1.2
MLH1 1.7 0.8 1.2 1.4 1.0 1.2 1.1 1.4 0.9 0.7
MLH3 2.5 0.8 1.0 1.2 0.8 1.2 1.6 1.4 1.0 0.7
MSH2 1.3 0.4 1.5 3.9 1.4 1.3 1.0 1.8 1.5 0.9
MSH3 1.4 1.0 1.2 1.2 1.3 0.9 0.7 1.5 0.7 0.5
MSH5 0.9 0.9 1.1 1.3 1.1 1.5 1.4 1.3 1.3 1.0
MSH6 0.4 0.4 0.9 2.2 0.4 1.1 2.5 0.9 0.7 0.8
Muts 0.6 1.5 1.5 1.0 1.5 1.3 0.9 2.2 2.3 1.1
PMS1/PMS2 0.7 1.0 0.7 0.7 0.5 0.8 1.6 0.7 0.7 1.1
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Table 1. Cont.




wt Ppatm-1 Ppatr-1 Ppatmatr-1









Nucleotide Excision, Base Excision, and UV Repair
DDB1 (1) 1.1 1.0 0.9 0.9 0.8 0.7 0.8 0.8 1.0 1.3
DDB1 (2) 0.8 1.0 1.5 1.5 1.4 1.2 0.9 1.1 1.1 1.0
DDB2 3.6 0.9 2.5 2.8 1.6 1.5 0.9 2.9 1.0 0.3
ERCC1/Rad10 (1) 0.8 0.9 1.0 1.1 0.8 0.9 1.1 1.2 1.1 0.9
ERCC1/Rad10 (2) 1.1 0.3 0.4 1.3 1.3 0.2 0.2 5.0 0.3 0.1
ERCC2/XPD 2.4 0.5 1.8 3.6 1.1 0.9 0.8 1.6 1.8 1.1
ERCC3/Rad25/XPB 1.0 0.7 1.2 1.7 1.0 0.9 0.9 0.8 1.1 1.5
ERCC5/RAD2 1.0 1.1 1.0 0.9 1.0 1.1 1.1 0.9 1.0 1.1
ERCC6/rad26 (1) 4.8 1.3 4.5 3.5 2.3 2.7 1.2 3.1 1.8 0.6
ERCC6/rad26 (2) 0.8 0.8 0.8 0.9 0.6 0.9 1.5 0.9 0.9 1.0
RAD16 (1) 1.3 0.7 2.2 3.1 1.8 1.8 1.0 2.2 1.9 0.9
RAD16 (2) 0.6 1.4 1.9 1.3 1.5 1.3 0.8 1.5 1.5 1.0
RAD23 (1) 0.5 0.9 0.7 0.7 0.7 0.8 1.3 0.8 0.8 1.0
RAD23 (2) 0.4 1.2 1.1 0.9 1.1 0.8 0.7 1.0 1.5 1.5
RAD23 (3) 1.9 1.1 1.2 1.1 1.6 0.7 0.4 2.4 1.1 0.5
RAD27/FEN1 (1) 3.5 1.3 1.7 1.3 0.9 2.0 2.3 2.0 2.8 1.4
RAD27/FEN1 (2) 2.1 0.8 1.4 1.7 0.4 1.5 4.3 1.4 1.0 0.7
RAD6/UBC2 (1) 1.0 1.1 1.1 1.1 1.1 1.1 1.0 1.5 1.1 0.7
RAD6/UBC2 (2) 1.0 0.6 0.7 1.1 0.8 0.9 1.1 0.8 0.8 1.0
SYF1 1.5 1.1 0.8 0.7 1.1 1.4 1.3 1.3 1.6 1.2
XPC/Rad4 1.1 0.3 2.9 10.0 1.5 1.6 1.1 0.2 0.8 4.2
XPF/ERCC4/RAD1 1.5 0.5 1.4 3.0 1.2 1.1 1.0 1.1 1.4 1.3
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Table 1. Cont.




wt Ppatm-1 Ppatr-1 Ppatmatr-1









ATM and ATR Interactors
Cdc5l 1.4 0.6 1.6 2.9 2.0 1.4 0.7 1.1 1.8 1.6
CHD family (1) 0.5 0.8 1.1 1.3 1.0 0.7 0.8 1.0 0.8 0.8
CHD family (2) 0.5 1.0 0.8 0.8 0.8 1.0 1.3 0.9 1.0 1.1
E2F1 1.0 0.8 0.6 0.7 1.0 0.7 0.8 1.2 1.2 0.9
H2A(1) 1.1 1.4 2.0 1.4 1.4 1.1 0.8 1.5 1.4 0.9
H2A (2) 0.8 1.0 1.4 1.4 0.8 0.8 1.0 0.9 1.0 1.0
HDAC1 (1) 0.5 0.6 1.3 2.2 0.7 0.9 1.3 0.8 0.8 1.0
HDAC1 (2) 1.3 1.1 0.9 0.8 0.9 1.0 1.1 1.3 1.8 1.3
HDAC1 (3) 1.2 0.8 1.4 1.9 1.3 1.1 0.8 2.7 1.2 0.5
MCM7 0.5 1.4 0.5 0.3 0.7 0.6 0.9 0.5 1.1 2.5
PTPA (1) 1.0 0.7 1.1 1.7 0.7 0.8 1.0 0.9 1.0 1.0
PTPA (2) 0.1 0.5 0.4 0.7 0.3 0.1 0.5 0.7 0.6 0.8
RENT1 (UPF1) (1) 0.4 0.6 1.0 1.7 0.8 1.5 1.9 0.6 1.5 2.6
RENT1 (UPF1) (2) 1.1 1.1 0.7 0.6 1.1 1.0 0.9 0.3 1.5 4.2
RFA1 (RPA) 1.2 0.8 2.3 2.8 0.8 1.1 1.4 1.1 0.8 0.8
RFA2 (RPA) 1.1 1.3 0.8 0.6 1.4 1.4 1.0 1.2 1.4 1.2
SOSB1/hSSB1 0.6 1.2 1.1 0.9 0.8 1.4 1.6 0.6 0.8 1.3
STRAP (1) 0.6 1.1 0.4 0.4 1.3 0.7 0.6 0.9 0.7 0.8
STRAP (2) 0.7 0.7 0.7 0.9 0.8 0.8 1.1 0.9 0.7 0.8
TERF family (1) 0.6 0.7 0.4 0.6 0.5 0.6 1.2 0.5 0.6 1.2
TERF family (2) 1.8 1.1 1.9 1.7 1.9 1.4 0.7 1.9 0.8 0.4
TERF family (3) 0.8 0.9 0.6 0.6 1.0 0.9 0.9 1.0 1.1 1.1
TERF family (4) 2.2 0.8 1.4 1.7 1.9 2.5 1.3 2.1 2.2 1.1
TERF family (5) 1.9 0.7 0.9 1.3 1.0 1.0 1.0 1.3 0.3 0.2
Column 1 shows the wild type differential expression profile obtained after bleomycin induction expressed as the transcript ratio (fold change) between bleomycin-treated and -untreated
samples (wtBleo/wt0). The corresponding data for the mutants are shown in columns 2, 3, and 4. Basal transcript profiles in the absence of DNA damage (fold change mutant/wt0)
follow differential expression profiles calculated for the changes relative to untreated wild type (fold change mutant Bleo/wt0) and untreated mutant (fold change mutant Bleo/mutant (0).
Twofold and higher changes in expression are highlighted, with increases in red and decreases in blue. Non-identical transcripts of identical orthologues are distinguished by numbers in
brackets. Genes are grouped in pathways and names are abbreviated in UniProt nomenclature with human names given preference over yeast, fission yeast, and plants. Full gene names,
aliases, and descriptions are available at https://www.uniprot.org/ and https://www.genecards.org/.
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4. Discussion
The mutations in the P. patens ATM and ATR genes were produced by deletion of the PI3K
and FAT-C domains located in the carboxyl-terminal regions of the proteins. The PI3K kinase
domain is essential for function in mammalian cells [43–45], suggesting that the mutated proteins
are unable to phosphorylate any downstream target proteins, their only well-documented activity.
Consequently, Ppatm-1 and Ppatr-1 are likely loss of function mutants, but both genes may still be
expressed and the remaining protein portions retain a residual function. Such mutants may differ in
phenotype from mutants created in different ways, as generally observed with different mutations in
the same gene.
Both Ppatm-1 and Ppatr-1 displayed phenotypes during their vegetative growth phase (Figure 2).
The Ppatm-1 mutant progressed slightly faster through the natural succession of growth transitions,
but was otherwise normal. The Ppatr-1 mutant displayed a severe and complex phenotype with all
developmental stages affected, beginning with the chloronema to caulonema transition. Later, and and
in dependence on growth conditions, the establishment of morphologically complex structures such as
gametophores and sporophytes was progressively inhibited in Ppatr-1 and even more so in Ppatmatr-1,
but was normal in Ppatm-1. These growth aberrations may have originated in the defects in the
DDR (Table 1) and/or cell-cycle checkpoint control (Figure 3C) that are more severe in Ppatr-1 and
Ppatmatr-1 and could affect long-term viability. Sporadic cell death in complex structures like the
gametophore, gametangia, and the diploid sporophyte could substantially cause growth aberrations
and consequently cause the phenotypes observed in these mutants. By contrast, mutations in ATM or
ATR in A. thaliana cause no obvious vegetative phenotype, in line with mutations in other recombination
genes (e.g., RAD51) [24–29] that cause phenotypes in P. patens but not in A. thaliana. The differences
in ATM and ATR and the other recombination genes suggest a tight connection of DNA damage
repair to developmental processes in P. patens that does not exist in A. thaliana, independently of the
mechanisms that may cause these phenotypes. The role of ATM in meiosis also seems to differ between
P. patens and A. thaliana, in line with the differences in somatic recombination. ATM is important in
the recombinational processing of programmed meiotic DSBs [13] in A. thaliana, but not in P. patens,
as suggested by the unaltered sporulation capacity of the Ppatm-1 mutant.
An intriguing feature of P. patens is the high efficiency of gene targeting. Our analysis showed
that neither gene alone was critical for gene targeting, but together they were. Although ATM is not
important for gene targeting in mammalian cells also [56], this is a surprising result for ATR, given its
leading role in the DDR. A variety of recombination activities [27–29], including those with a central role
in HR, RAD51, and RAD51 paralogue B, [24–26,30], have been analyzed in P. patens. Collectively, these
analyses suggest that gene targeting and direct DSB repair use common recombination pathways
in P. patens, at least up to the point where HR diverges [6,7] into the gene conversion and crossover
HR sub-pathways. The concurrent dependence of resistance to bleomycin and upregulation of main
DSB repair activities (9-1-1, PARP2, HR, and NHEJ) on ATR suggests that transcriptional regulation
plays an essential role in direct DSB repair. Gene targeting efficiency is barely affected in the Ppatr-1
mutant, but almost completely lost in the Ppatmatr-1 double mutant. However, the main DSB repair
activities are not significantly more affected than in Ppatr-1 (Table 1), suggesting that transcriptional
regulation of DSB repair pathways plays no or only a minor role in gene targeting. This may be so
because sufficient amounts of repair activities pre-exist to support gene targeting, but not DSB repair.
Alternatively, ATM and ATR may redundantly be involved in transcriptional control of other repair
pathways or mechanisms that are less important for DSB repair but critical for gene targeting, such
as the switch between gene conversion and crossover HR. However, the repertoire of ATM and ATR
functions is not limited to transcriptional regulation. Phosphorylation of downstream targets is an
important function to consider as well as the involvement of these kinases in other stress responses and
cell-cycle control. Consequently, any of these could be relevant for gene targeting and/or could be the
primary determinant of the unexpected and yet unexplained increase in transformation efficiency in
both single mutants (Figure 4A). Whatever these functions in detail may be, our data point to important
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differences in the regulatory circuits controlling direct DSB repair and gene targeting and consequently
in the functions of ATM and ATR between them.
ATM and ATR are important in cell-cycle checkpoint control in mammals and A. thaliana [15].
In P. patens, ATM has limited importance in checkpoint control and ATR is dominant. ATR also
dominates transcriptional regulation in the DDR of P. patens and controls induction of early responding
components (9-1-1 complex, PARP2) and the major DSB repair pathways (HR and NHEJ) (Table 1).
Moreover, ATR almost exclusively controls the establishment of resistance to bleomycin while ATM’s
contribution seems to be restricted to proliferating cells. The minor role of ATM is consistent with the
minimal importance of NBS1, a direct ATM interaction partner involved in the recognition of direct
DSBs in DNA damage repair in P. patens [27]. The relative roles of ATM and ATR are comparable to
their counterparts in yeast. Tel1 (ATM) contributes only marginally to direct DSB repair, has little
importance in checkpoint control [57], and plays only a secondary role in signaling pathways [58,59],
whereas these processes are dominated by Mec1 (ATR). This suggests that the P. patens proteins have
yeast-like functions with ATR as the master coordinator in the DDR. By contrast, A. thaliana atm mutants
display marked sensitivity to direct DSB-inducing agents and the transcriptional response is largely
dependent on ATM [13–15,17,18], indicating that ATM and ATR are functionally specialized like in
mammals. These differences imply a substantial divergence of ATM and ATR function between A.
thaliana and P. patens. However, although similar, P. patens ATM and ATR functions are not identical
to yeast since signaling in metazoa and yeast is largely mediated through two important acceptor
kinases, CHK1 and CHK2 (RAD53) [2,8,10,60], both of which do not exist in the A. thaliana and P. patens
genomes (Table S1). Their absence suggests major differences in the DDR between plants and other
eukaryotes, indicating additional differences in ATM and ATR downstream signaling and consequently
in their function in cell-cycle checkpoint control and DNA damage repair. The absence of the third
PIKK in the DDR, PRKDC, in A. thaliana and the BRCA2 and BRCA1 orthologues in P. patens suggests
that such differences also exist between plants (Table S1). These differences suggest a high degree of
divergence in important components of the DDR and downstream DNA damage repair pathways
across major eukaryotic lineages and, consequently, the existence of major mechanistic differences
among them.
A. thaliana and P. patens share a common ancestor, but have different preferences for direct DSB
repair pathways—NHEJ in A. thaliana and mammals and HR in P. patens [24] and yeast—with the
high efficiency of gene targeting possibly reflecting the latter preference. The correspondence of DSB
repair pathway choice to yeast- or human-like ATM and ATR features in these organisms suggests that
these are the adaptations in the DDR necessary to follow these preferences. P. patens is a relatively
direct descendant of the first genetically haploid, land-colonizing plants. The conditions prevailing at
that time likely caused massive intracellular genotoxic and general stress, for instance through the
production of reactive oxygen species or by constant dehydration/rehydration cycles. These conditions
may have required special mechanisms for the maintenance of genome stability that were maintained
by selection through the environmental conditions in its present day habitat. HR for direct DSB repair
together with cell-cycle arrest in G2 or late S phase [36,61] provides a mechanism for precise and
efficient DNA damage repair. A homologous DNA template that is obviously lacking in the haploid
vegetative phase of P patens is provided by shortening of the G1 phase such that cell-cycle arrest
preferentially occurs in G2 or late S phase, thereby providing a sister chromatid for homology-mediated
DSB repair most of the time. Inhospitable conditions faced by yeast in its natural environment [62]
may have similarly promoted the use of HR for DSB repair and consequently the adaptation of ATM
and ATR to this preference. These connections suggest that yeast-like ATM and ATR features could
have relevance for gene targeting.
5. Conclusions
In essence, the divergence in ATM and ATR features between A. thaliana and P. patens, as well
as other organisms, are likely adjustments in the DDR required for the alternate use of DSB repair
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pathways that is driven by differing requirements for the maintenance of genome stability under
different environmental conditions. Such an evolutionary selection mechanism predicts a much higher
diversity in ATM and ATR functions between species that is entirely independent of their affiliation to
individual taxonomic lineages. In support of this hypothesis, human-like genes exist in all vertebrates
and A. thaliana and exist in yeast-like forms in yeast, fission yeast (Schizosaccharomyces pombe), the insect
Drosophila melanogaster, and the bryophyte P. patens [3,10,13,16,60,63], suggesting that such diversity
indeed exists. Moreover, their existence in disparate eukaryotic lineages such as metazoa, plants,
and yeast suggests that these forms have evolved independently multiple times in several different
lineages and kingdoms.
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